trial · primary record
Cyclophosphamide
Endocrine Tumors
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 285 |
| Primary completion | 2029-03-23 |
| Primary endpoint | Response rate |
| Registry ID | NCT03412877 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:40:30.789Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT03412877
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Cyclophosphamide · approval
- cyclophosphamide · compound